Literature DB >> 2967522

Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results.

G Forni, G P Cavallo, M Giovarelli, G Benetton, C Jemma, M G Barioglio, A De Stefani, M Forni, A Santoni, A Modesti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2967522     DOI： 10.1159/000414679

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  8 in total

Review 1.  Local and regional immunotherapy of cancer with interleukin 2.

Authors:  J Bubeník
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type.

Authors:  E Kedar; R Ben-Aziz; E Epstein; B Leshem
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study.

Authors:  V Serretta; G Corselli; B Piazza; D Lio; F Gervasi; S Salerno; M Pavone-Macaluso
Journal:  Urol Res       Date:  1993

4.  Histologic and immunohistochemical characterization of tumor and inflammatory infiltrates in oral squamous cell carcinomas treated with local multikine immunotherapy: the macrophage at the front line.

Authors:  Meora Feinmesser; Elimelech Okon; Ariel Schwartz; Ella Kaganovsky; Britta Hardy; Elena Aminov; Ben Nageris; Jaqueline Sulkes; Raphael Feinmesser
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

Review 5.  Interferons and other cytokines in head and neck cancer.

Authors:  V K Hamasaki; E E Vokes
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

6.  Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo.

Authors:  S M Dubinett; L Patrone; J Tobias; A J Cochran; D R Wen; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 7.  Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy.

Authors:  G Forni; H Fujiwara; F Martino; T Hamaoka; C Jemma; P Caretto; M Giovarelli
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

8.  Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder.

Authors:  M Milella; J Jacobelli; F Cavallo; A Guarini; F Velotti; L Frati; R Foà; G Forni; A Santoni
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.